Give me answers according to weightage of the questions from que 1-4 in both section... give me concised answers only what is asked in questions

Reading File

Finding Sources

All questions answered. Here's a quick summary of what's covered:

Coverage Summary - Both Sections, Q1-Q4:

Question	Marks	Content Covered
Sec I Q1	10	Atonic PPH stepwise management + 3rd stage complications; RH isoimmunization management
Sec I Q2	12	Case A: IDA investigations + management + diagnosis; Case B: Abruptio placentae diagnosis, management, complications; Case C: Septic abortion diagnosis, investigations, management
Sec I Q3	18	All 4 short notes fully covered
Sec I Q4	10	All 6 options answered in 2-3 sentences each
Sec II Q1	10	Fallopian tube anatomy + all 4 parts (a-d) sterilization; Precocious puberty complete
Sec II Q2	12	All 3 cases answered with diagnosis, supports, management
Sec II Q3	18	All 4 short notes (Pap smear, Male infertility, PCOS, Vaginal infections)
Sec II Q4	10	All 6 options answered in 2-3 sentences each

Key points calibrated to mark weightage - 10-mark answers are detailed, 6-mark short notes are structured, and 2-mark answers are 2-3 sentences only. Good luck!

Where did all the content go

The content is all there! It's a very long response - you need to scroll up in the chat to see it all.

Here's what was answered:

SECTION I:

Q1 (10 marks): Atonic PPH stepwise management + 3rd stage complications / RH isoimmunization
Q2 (12 marks): All 3 cases - IDA, Abruptio placentae, Septic abortion
Q3 (18 marks): Physiological changes, Multifetal gestation, Obstructed labour, ANC 2nd trimester
Q4 (10 marks): MMR, IUGR, RDS, Molar pregnancy, Partograph, Breastfeeding

SECTION II:

Q1 (10 marks): Fallopian tube anatomy + all sterilization parts (a-d) / Precocious puberty
Q2 (12 marks): Uterovaginal prolapse, Menorrhagia with fibroid, Vaginal discharge with Copper-T
Q3 (18 marks): Pap smear, Male infertility, PCOS, Vaginal infections (with comparison table)
Q4 (10 marks): IUDs, Ovulation induction, Dysmenorrhoea, HRT, D&C, Laparoscopy

Just scroll up - everything is there in full detail. If any specific question's answer got cut off on your screen, let me know which one and I'll repost it.

Give me answer to Q-1

Asking for Preferences

SECTION I — Q.1 (10 Marks)

Write in detail (any one of two)

Option 1: Complications of Third Stage of Labour + Stepwise Management of Atonic PPH

Complications of Third Stage of Labour

Postpartum Haemorrhage (PPH) - most common; defined as blood loss >500 mL after vaginal delivery or >1000 mL after LSCS
Retained placenta - placenta not expelled within 30 minutes of delivery
Placenta accreta / increta / percreta - abnormal adherence of placenta
Uterine inversion - fundus inverts through the cervix (rare but life-threatening)
Amniotic fluid embolism
Coagulopathy / DIC
Cervical and vaginal lacerations
Uterine rupture (extension from 2nd stage)

Stepwise Management of Atonic PPH

Atonic PPH = uterus fails to contract after delivery = responsible for 80% of all PPH cases

Step 1 - Simultaneous Resuscitation

Call for senior help
2 large-bore IV cannulas (16G)
IV crystalloids: Ringer's lactate / Normal saline
Blood grouping, crossmatching, CBC, coagulation profile, LFT, RFT
Oxygen by face mask
Foley catheter (monitor urine output - target >30 mL/hr)

Step 2 - Uterine Massage

Bimanual uterine compression (one hand in vagina, one on abdomen)
Rub up a contraction
Expel clots from uterus

Step 3 - Uterotonics (stepwise)

Drug	Dose & Route
Oxytocin (1st line)	10 IU IM or 20 IU in 500 mL NS IV infusion at 40 drops/min
Ergometrine	0.25 mg IM or slow IV (avoid in hypertension)
Carboprost (PGF2α)	250 mcg IM every 15 min; max 8 doses
Misoprostol	800-1000 mcg rectal / sublingual
Tranexamic acid	1g IV over 10 min; repeat if bleeding continues after 30 min

Step 4 - Intrauterine Balloon Tamponade

Bakri balloon inflated with 300-500 mL saline
Condom catheter tamponade (in resource-limited settings)
Uterine gauze packing
If balloon works = "positive tamponade test" → avoid surgery

Step 5 - Surgical (if above fails)

Procedure	Description
B-Lynch compression suture	Brace suture encircling the uterus longitudinally
Haemostatic square sutures	Multiple interrupted sutures on the uterine wall
Uterine artery ligation	O'Leary suture bilaterally
Internal iliac artery ligation	Reduces pulse pressure to uterus by 85%
Obstetric hysterectomy	Last resort; life-saving; peripartum hysterectomy

Step 6 - Interventional Radiology (if stable)

Uterine artery embolization - preserves uterus, good for placenta accreta

Option 2: RH Isoimmunization — Definition + Management

Definition

RH isoimmunization occurs when an Rh-negative mother is exposed to Rh-positive fetal red blood cells, producing anti-D IgG antibodies that cross the placenta and cause Haemolytic Disease of the Fetus and Newborn (HDFN).

The most important sensitizing antigen is the D antigen. Once sensitized, subsequent Rh+ pregnancies carry increasing risk of fetal haemolysis, hydrops, and death.

Management of RH Isoimmunized Pregnancy

At Booking (First Visit)

Blood group + Rh typing for all pregnant women
Indirect Coombs Test (ICT) - if negative, repeat at 28 and 36 weeks
If ICT positive → titre measured; if ≥ critical titre (1:8 to 1:16) → refer to tertiary centre

Fetal Surveillance

Investigation	Details
MCA Doppler (Middle Cerebral Artery PSV)	Gold standard - PSV >1.5 MoM = fetal anaemia; done from 18 weeks, every 1-2 weeks
Amniocentesis	ΔOD450 on Liley's / Queenan's chart - largely replaced by MCA Doppler
Cordocentesis	Direct fetal blood sampling for Hb, haematocrit, reticulocytes - most accurate

Intrauterine Transfusion (IUT)

Indications: Fetal Hb < 8 g/dL or haematocrit < 30% (MCA PSV > 1.5 MoM)
Blood used: O-negative, CMV-negative, irradiated, leucodepleted packed RBCs
Route: Intravascular (umbilical vein via cordocentesis) preferred
Can be repeated every 2-3 weeks until delivery

Timing of Delivery

Mild/no anaemia: 37-38 weeks
After IUT: 34-37 weeks depending on number of transfusions
Give corticosteroids (betamethasone) for lung maturity if delivery < 34 weeks
NICU standby essential

Neonatal Management

Phototherapy for jaundice
Exchange transfusion if bilirubin rising rapidly or Hb < 10 g/dL at birth
IV Immunoglobulin (IVIG) to slow haemolysis

Prevention (Anti-D Prophylaxis)

Indication	Dose
28 weeks (antenatal prophylaxis)	300 mcg anti-D IM
After delivery of Rh+ baby (within 72 hrs)	300 mcg anti-D IM
After sensitizing events (miscarriage, amniocentesis, APH, ECV, trauma)	300 mcg IM

Kleihauer-Betke test - quantifies fetal cells in maternal blood; guides need for extra anti-D dose in large fetomaternal haemorrhage

Now sec 1 all answers of Q2

SECTION I — Q.2 (12 Marks)

Case Scenario Based Questions (any two of three — 6 marks each)

CASE A: 32-year-old G5, 5 months amenorrhoea, breathlessness + fatigue on exertion, pallor, pedal oedema, tachycardia

1. How do you investigate the case?

To confirm anaemia and type:

CBC - Hb, MCV, MCH, MCHC (hypochromic microcytic = IDA)
Peripheral blood smear - pencil cells, microcytes, hypochromia, anisocytosis, poikilocytosis
Serum ferritin - best marker of iron stores (low in IDA, even before Hb falls)
Serum iron - low in IDA
TIBC (Total Iron Binding Capacity) - elevated in IDA
Transferrin saturation - <15% in IDA
Reticulocyte count - low in IDA (inadequate erythropoiesis)

To find cause of anaemia:

Urine R/M - haematuria, proteinuria
Stool for occult blood, ova and cysts - hookworm (most common cause of IDA in India)

Obstetric investigations:

Obstetric USS - gestational age, fetal growth, placental location
Blood group and Rh typing

To exclude other causes (if clinically indicated):

Serum B12 / folate (megaloblastic anaemia)
Haemoglobin electrophoresis (sickle cell, thalassaemia in high-risk)
TFT (thyroid function)
ECG / Echo (tachycardia + oedema may indicate cardiac involvement in severe anaemia)

2. Management of Moderate Iron Deficiency Anaemia at 24 Weeks

Moderate anaemia = Hb 7–10 g/dL

Oral Iron (first line):

Ferrous sulphate 200 mg TDS (contains ~60 mg elemental iron per tablet)
Take on empty stomach for better absorption
Vitamin C 100 mg with each dose (enhances absorption)
Folic acid 5 mg/day
Dietary counselling: green leafy vegetables, jaggery, meat, lentils, citrus fruits
Expected rise: 1 g/dL per week; continue for 3 months after Hb normalizes (replenish stores)

Parenteral Iron (if oral not tolerated/non-compliant/malabsorption):

Iron sucrose IV - 200 mg in 100 mL NS over 30 minutes; can repeat every 48 hours
Ferric carboxymaltose - up to 1000 mg single dose IV
Faster response, better compliance
Monitor for anaphylaxis (especially with iron dextran)

Blood Transfusion:

Only if Hb < 6 g/dL or near term (>36 weeks) or haemodynamically compromised
Packed red cells (1 unit raises Hb by ~1 g/dL)

Follow-up:

Repeat Hb every 2-4 weeks
Monitor fetal growth with serial USS (anaemia → IUGR)

3. Probable Diagnosis

Iron Deficiency Anaemia (moderate) in pregnancy - most common cause of anaemia in pregnancy in India (accounts for >50%)
Contributing factors: G5 (multiparity depletes iron stores), 24 weeks gestation (increased fetal demand), likely dietary deficiency ± hookworm infestation
Differential diagnoses:
- Anaemia of chronic disease
- Folate deficiency (megaloblastic anaemia)
- Thalassaemia trait

CASE B: 27-year-old Primigravida, 34 weeks, abdominal pain + bleeding PV, pallor, tense and tender uterus, FHS not localized

1. Probable Diagnosis

Abruptio Placentae (Placental Abruption) — Concealed/Mixed type, Grade II-III

Reasoning:

Finding	Significance
Painful PV bleeding	Distinguishes from placenta praevia (painless)
Tense, board-like, tender uterus	Retroplacental haematoma distending uterus
FHS not localized	Fetal distress / possible IUFD
Pallor + tachycardia	Hypovolaemic shock (concealed blood loss > apparent)
Primigravida 34 weeks	Hypertension/pre-eclampsia most common trigger

Differential: Placenta praevia (painless, soft uterus), uterine rupture (sudden onset, loss of fetal parts on palpation)

2. Management Protocol

Immediate Resuscitation (ABC):

Admit to labour room / HDU
2 large-bore IV lines (16G)
IV Ringer's lactate / Normal saline rapidly
Oxygen by face mask at 6-8 L/min
Foley catheter - monitor urine output (target >30 mL/hr)

Investigations:

CBC, blood group + crossmatch (arrange 4-6 units blood)
Coagulation profile: PT, aPTT, fibrinogen (watch for DIC)
Serum urea, creatinine, electrolytes (renal function)
Urine for protein (pre-eclampsia)
Continuous CTG monitoring

Definitive Management:

If fetus alive (CTG showing distress or reassuring):

Emergency LSCS - treatment of choice at 34 weeks with live fetus + signs of compromise
Betamethasone 12 mg IM x2 doses (24 hrs apart) - if time allows, for fetal lung maturity
Neonatology/NICU team on standby

If fetus dead (IUFD):

Vaginal delivery preferred
Amniotomy + oxytocin augmentation
Watch closely for DIC (fibrinogen falls rapidly in IUFD)
LSCS only for obstetric indication

Manage DIC if present:

Fresh Frozen Plasma (FFP) - 4 units
Cryoprecipitate (fibrinogen)
Platelet concentrate if <50,000
Tranexamic acid 1g IV

Postpartum:

Watch for PPH (Couvelaire uterus has poor contractility)
Uterotonics prophylactically

3. Likely Obstetric Complications

Fetal/Neonatal:

IUFD (intrauterine fetal death)
Fetal distress - hypoxia from placental separation
Prematurity (34 weeks) - RDS, IVH, NEC, sepsis
IUGR (if chronic placental insufficiency preceded the abruption)

Maternal:

DIC - most dangerous; retroplacental blood activates coagulation cascade → consumption of clotting factors
Hypovolaemic shock - especially with concealed haemorrhage
Acute Renal Failure (Acute Tubular Necrosis) - from hypoperfusion
Couvelaire uterus (Uteroplacental apoplexy) - blood infiltrates myometrium → PPH, may need hysterectomy
Sheehan's syndrome - pituitary necrosis from prolonged hypotension → hypopituitarism postpartum
Recurrence in future pregnancies (10x increased risk)

CASE C: 21-year-old Primigravida, foul-smelling discharge PV, 2 months amenorrhoea, H/O MTP pills 1 month ago, tachycardia, fever 101°F, foul-smelling discharge on P/S

1. Diagnosis

Septic Incomplete Abortion following self-administered MTP pills (unsupervised medical abortion)

2 months amenorrhoea → ~8 weeks pregnancy
MTP pills (mifepristone + misoprostol) taken 1 month ago without medical supervision
Incomplete expulsion of products of conception → retained products → ascending infection → sepsis
Fever 101°F (38.3°C) + tachycardia + foul-smelling discharge = infected/septic abortion

2. Investigations

To assess infection and sepsis:

CBC with differential - leukocytosis, neutrophilia, left shift
Blood culture and sensitivity - before starting antibiotics (most important)
High vaginal swab + endocervical swab for C&S and Gram stain
CRP, procalcitonin (severity of sepsis)

To assess retained products:

Pelvic USS (TVS preferred) - retained products of conception (RPOC), uterine size, any pelvic collection
Serum β-hCG - confirms ongoing trophoblastic tissue

To assess complications:

Serum urea, creatinine, electrolytes - septic renal failure
LFT - hepatic dysfunction in sepsis
Coagulation profile (PT, aPTT, fibrinogen) - DIC screen
Blood grouping and Rh typing
Urine R/M and C&S - urinary source of sepsis

3. Management

Step 1 - Resuscitation and Stabilization:

Admit, strict bed rest
IV fluids (Ringer's lactate / NS) rapidly
O2 by mask
Vitals monitoring every 15-30 min
Foley catheter - monitor urine output

Step 2 - Broad-spectrum IV Antibiotics (start immediately, before evacuation):

Regimen	Drugs
Triple regimen (preferred)	Ampicillin 1g IV 6hrly + Gentamicin 80 mg IV 8hrly + Metronidazole 500 mg IV 8hrly
Alternative	Ceftriaxone 1g IV BD + Metronidazole 500 mg IV TDS
Oral step-down	After 48 hrs improvement → Amoxicillin-clavulanate + Metronidazole oral x7-10 days

Wait 4-6 hours after starting antibiotics before surgical evacuation (to reduce bacteraemia risk during procedure)

Step 3 - Surgical Evacuation of Retained Products:

Suction evacuation (MVA - manual vacuum aspiration) - preferred, gentle
OR D&C under anaesthesia if MVA not available
Send all products for histopathology

Step 4 - Additional Measures:

Tetanus prophylaxis if indicated
Analgesics (paracetamol IV for fever)
Transfusion if Hb < 8 g/dL

Step 5 - Post-recovery:

Counselling regarding legal and safe abortion services (MTP Act)
Contraception counselling - OCP, IUCD, injectable
Psychological support

Now sec 1 All answers for Q3

SECTION I — Q.3 (18 Marks)

Write a Short Note (any three of four — 6 marks each)

1. Physiological Changes in Haematology and Cardiology Systems in Pregnancy

Haematological Changes

Blood Volume:

Total blood volume increases by 40-45% (by ~1500 mL) starting from 6 weeks, peaking at 32-34 weeks
Plasma volume increases by 50%
RBC mass increases by only 20-25%
Net result: Dilutional/Physiological anaemia of pregnancy (Hb diluted despite absolute increase in RBCs)
Normal Hb in pregnancy: ≥11 g/dL (1st and 3rd trimester), ≥10.5 g/dL (2nd trimester)

RBCs:

MCV slightly increases (macrocytosis - normal in pregnancy)
Increased erythropoietin → increased erythropoiesis
Increased iron demand (~1000 mg total in pregnancy)

WBCs:

Leukocytosis: WBC rises to 12,000-15,000/mm³ in pregnancy
During labour: up to 20,000-25,000/mm³ (normal, stress response)
Predominantly neutrophilia

Platelets:

Slightly decreased (gestational thrombocytopenia) - dilutional + increased consumption
Usually remains >150,000; thrombocytopenia < 100,000 is pathological

Coagulation (Hypercoagulable state):

Factor	Change
Fibrinogen (Factor I)	Increases 50% (200→600 mg/dL)
Factors VII, VIII, IX, X, XII	All increase
ESR	Markedly elevated (not useful in pregnancy)
Protein S	Decreases
Protein C	No change
Antithrombin III	Slight decrease

Net result: Procoagulant state → increased risk of DVT and PE (5x normal)
Protective against haemorrhage at delivery

Cardiovascular Changes

Cardiac Output:

Increases 30-50% above non-pregnant levels
Peaks at 28-32 weeks
Due to: Heart rate ↑ by 15-20 bpm + Stroke volume ↑ by 25-30%
In labour: further increases by 50% with each contraction (pain + effort)
Returns to normal by 2 weeks postpartum

Heart Rate:

Resting HR increases by 15-20 bpm
Palpitations and ectopic beats are common (benign)

Blood Pressure:

Systolic: Slight decrease in 1st and 2nd trimester → returns to normal in 3rd trimester
Diastolic: Falls more markedly (progesterone → vasodilatation → reduced SVR)
SVR (Systemic Vascular Resistance): Decreases by 20-30% (progesterone + placental low-resistance circuit)
BP < 90/60 in 1st trimester is normal

Aortocaval Compression Syndrome (Supine Hypotension):

After 20 weeks, gravid uterus compresses inferior vena cava in supine position
Reduces venous return → reduced cardiac output → hypotension, dizziness, nausea
Prevention: left lateral decubitus position (wedge under right hip)

Position of Heart:

Uterus pushes diaphragm up → heart displaced upward and to the left
Apex beat shifted laterally

Clinical Findings (Normal in Pregnancy):

Physiological systolic flow murmur (grade 1-2) - due to increased flow
Third heart sound (S3) may be audible
Cardiomegaly on X-ray (borderline)
ECG: Left axis deviation, sinus tachycardia, ST changes, T-wave inversion in lead III (all normal)

2. Maternal and Foetal Complications of Multifetal Gestation

Maternal Complications

System	Complication
GI	Hyperemesis gravidarum (more severe, longer duration)
Haematological	Anaemia (iron + folate demands doubled)
Hypertensive	Gestational HTN, Pre-eclampsia (3x more common), Eclampsia
Metabolic	Gestational diabetes mellitus (increased incidence)
Mechanical	Polyhydramnios (especially in TTTS), Premature rupture of membranes
Placental	Placenta praevia, Abruptio placentae
Labour	Preterm labour (most common complication - 50% deliver before 37 weeks)
Postpartum	PPH (uterine overdistension → atony), Retained placenta
Surgical	Higher rate of LSCS, operative delivery

Foetal / Neonatal Complications

Common to all multifetal gestations:

Preterm delivery (leading cause of neonatal morbidity and mortality)
- RDS (respiratory distress syndrome)
- Intraventricular haemorrhage (IVH)
- Necrotizing enterocolitis (NEC)
- Sepsis
IUGR / FGR - selective or affecting both fetuses (crowding + insufficient placental reserve)
Malpresentation - cord prolapse, birth trauma, shoulder dystocia
Congenital anomalies - higher incidence in monozygotic (MZ) twins

Specific to Monochorionic (MC) Twins:

Complication	Features
TTTS (Twin-to-Twin Transfusion Syndrome)	Donor twin: anaemia, oligohydramnios, IUGR; Recipient twin: polycythaemia, polyhydramnios, cardiac overload; 15-20% of MC-DA twins
TAPS (Twin Anaemia Polycythaemia Sequence)	Chronic unequal RBC transfusion without fluid imbalance
sIUGR (selective IUGR)	One twin severely growth restricted
TRAP sequence	Acardiac twin - parasitic twin with reversed arterial perfusion
Cord entanglement	Monoamniotic (MA) twins - risk of cord accidents, IUFD
Death of one twin	In MC: dead twin releases thromboplastins → DIC / neurological damage (multicystic encephalomalacia) in surviving co-twin

3. Obstructed Labour

Definition

Labour in which, despite adequate uterine contractions, the presenting part fails to descend through the birth canal due to a mechanical obstruction.

Causes

Passenger (fetal) factors:

Malpresentation: Brow presentation (most common cause), Shoulder presentation (transverse lie), Face (mentoposterior)
Malposition: Deep transverse arrest, Persistent occipitoposterior (OP) position
Fetal macrosomia, hydrocephalus, locked twins

Passage (pelvic) factors:

Cephalopelvic disproportion (CPD) - most common overall cause
Contracted pelvis (flat, android, generally contracted)
Pelvic tumours: fibroid, ovarian cyst, cervical fibroid

Cervical factors:

Annular detachment, cervical rigidity (rare)

Clinical Features

Feature	Significance
Prolonged labour, no progress	>12 hrs active phase with no descent/dilation
Bandl's retraction ring	Visible ridge between upper and lower uterine segment - ominous sign of impending rupture
Oedematous, thick anterior lip of cervix	Compressed between head and pubis
Caput succedaneum (large, 3+) and moulding (3+)	Prolonged pressure on fetal head
Maternal exhaustion, dehydration, ketosis	Prolonged labour
Maternal tachycardia, fever	Dehydration, infection
Haematuria	Bladder compressed between head and pubis → pressure necrosis
Fetal distress (IUFD)	Cord compression, hypoxia

Management

Immediate:

IV fluids (correct dehydration, ketosis)
Broad-spectrum IV antibiotics (infection risk)
Foley catheter
Correct maternal electrolytes
Assess cause (clinical + USS if needed)

Definitive:

LSCS - treatment of choice if fetus is alive
- Guard against: difficult delivery of impacted head (use Patwardhan's or reverse breech extraction)
If fetus is dead (IUFD in resource-limited settings):
- Craniotomy (for vertex) - destructive operation to reduce head size
- Decapitation (for shoulder/transverse lie)
- Evisceration

Complications

Maternal:

Uterine rupture - most catastrophic; can be silent or dramatic
Obstetric fistula - VVF (vesicovaginal) or RVF (rectovaginal) - pressure necrosis from prolonged impaction
Sepsis, peritonitis
PPH (exhausted uterus)
Maternal death

Fetal:

Fresh stillbirth
Birth asphyxia → HIE (hypoxic ischaemic encephalopathy)
Intracranial haemorrhage, fractures

4. Components of Antenatal Care in 2nd Trimester (13–28 Weeks)

Recommended Visits

14-16 weeks (early 2nd trimester)
24-28 weeks (late 2nd trimester - GDM screen + anti-D)

History and Symptoms to Enquire

Quickening (fetal movements) - felt from 18-20 weeks in primigravida, 16-18 weeks in multigravida
Bleeding PV, discharge, dysuria, headache, visual disturbances, oedema

Examination

Parameter	Normal Finding
Weight gain	0.5 kg/week in 2nd trimester; total ~5 kg in 2nd trimester
Blood Pressure	Should be <140/90; diastolic normally low in 2nd trimester
Fundal height	20 weeks = at umbilicus; 24 weeks = 24 cm (McDonald's rule)
Fetal heart sounds	Doppler from 12 weeks; Pinard from 20 weeks (120-160 bpm)
Oedema	Mild pedal oedema - physiological

Investigations in 2nd Trimester

Investigation	When	Purpose
CBC / Hb	14-16 weeks, 28 weeks	Anaemia screening
Anomaly scan (USS)	18-20 weeks	Structural anomalies, NT, placental localization, AFI, fetal growth
GDM screening	24-28 weeks	75g OGTT (WHO) or 50g GCT (screening)
Urine R/M	Every visit	Proteinuria (pre-eclampsia), UTI
ICT	28 weeks	Rh-negative mothers - sensitization check
Quadruple marker test	15-20 weeks	Down's syndrome screening (AFP, β-hCG, uE3, inhibin A)

Interventions and Prophylaxis

Intervention	Details
Iron + Folic acid	Ferrous sulphate 100 mg + Folic acid 500 mcg daily (throughout)
Calcium supplementation	1 g/day from 20 weeks - reduces pre-eclampsia risk
TT vaccination	TT1 at 16 weeks, TT2 at 20 weeks (4 weeks apart); protects against neonatal tetanus
Anti-D	300 mcg IM at 28 weeks for Rh-negative mothers (if not sensitized)
Low-dose aspirin	75-150 mg/day from 12-16 weeks if high risk for pre-eclampsia

Counselling

Fetal movement counting (kick chart) from 28 weeks
Nutrition and diet advice (protein, iron-rich foods, avoid raw meat)
Exercise - moderate walking encouraged
Avoidance of alcohol, smoking, teratogenic drugs
Danger signs - when to report immediately: bleeding, severe headache, visual disturbances, reduced fetal movements, leaking PV
Birth preparedness and complication readiness plan
Breast preparation for feeding

Now sec 1 all answers for Q4

SECTION I — Q.4 (10 Marks)

Write in 2-3 Sentences (any 5 of 6 — 2 marks each)

1. Define Maternal Mortality Rate (MMR)

MMR is defined as the number of maternal deaths per 100,000 live births in a given year, from causes related to or aggravated by pregnancy or its management (excluding accidental/incidental causes), occurring during pregnancy or within 42 days of termination of pregnancy.

A maternal death is classified as direct (obstetric causes - haemorrhage, sepsis, eclampsia, obstructed labour, unsafe abortion) or indirect (pre-existing disease aggravated by pregnancy - anaemia, cardiac disease, malaria).

India's MMR has declined significantly from 556 (1990) to 97/100,000 live births (SRS 2018-20), though the SDG target is ≤70 by 2030.

2. Define IUGR with Its Types

IUGR (Intrauterine Growth Restriction) is a condition where the fetus fails to achieve its genetically determined growth potential, with estimated fetal weight below the 10th percentile for gestational age, due to pathological causes (distinguished from Small for Gestational Age which may be constitutionally small).

Type I - Symmetrical IUGR (20-30%): All body parameters (HC, AC, FL) reduced proportionately; HC:AC ratio normal; results from early insult (1st trimester) - chromosomal anomalies, TORCH infections, teratogens; poor prognosis as cell number itself is reduced.

Type II - Asymmetrical IUGR (70-80%): Abdominal circumference reduced but head relatively spared (brain-sparing effect); HC:AC ratio elevated; results from late insult (3rd trimester) - uteroplacental insufficiency, pre-eclampsia, maternal anaemia; better prognosis as cell size is reduced (catch-up growth possible).

3. Respiratory Distress Syndrome (RDS)

RDS (Hyaline Membrane Disease) is a condition of premature neonates caused by deficiency of surfactant (dipalmitoyl phosphatidylcholine, produced by Type II pneumocytes), leading to high alveolar surface tension, progressive alveolar collapse (atelectasis), and respiratory failure; risk inversely proportional to gestational age (most common <34 weeks).

Clinical features appear within 4-6 hours of birth: expiratory grunting, intercostal and subcostal retractions, nasal flaring, tachypnoea (>60/min), and central cyanosis; chest X-ray shows ground-glass appearance with air bronchograms and reticulogranular pattern.

Prevention: Antenatal corticosteroids (betamethasone 12 mg IM × 2 doses, 24 hrs apart) given to mothers at 24-34 weeks at risk of preterm delivery accelerate fetal lung maturity; Treatment: Exogenous surfactant instillation intratracheally + CPAP or mechanical ventilation.

4. What is Molar Pregnancy?

Molar pregnancy (Hydatidiform Mole) is an abnormal form of pregnancy and the most common type of Gestational Trophoblastic Disease (GTD), characterized by abnormal proliferation of trophoblastic tissue with hydropic degeneration of chorionic villi, resulting from abnormal fertilization.

Complete mole (46XX, entirely paternal chromosomes, no fetal parts) presents with exaggerated pregnancy symptoms, uterus large for dates, very high β-hCG, snowstorm pattern on USS, and carries 2-3% risk of choriocarcinoma; Partial mole (triploid 69XXY, some fetal parts present) has lower malignancy risk (~0.5%).

Management: Suction evacuation + histopathological confirmation + serial β-hCG monitoring every 2 weeks until 3 consecutive normal values, then monthly for 6-12 months; reliable contraception (OCP preferred) for 1 year (complete mole) or 6 months (partial mole) to allow accurate monitoring.

5. Partograph and Its Importance

A partograph is a pre-printed graphical record used to monitor labour progress, maternal condition, and fetal wellbeing on a single sheet, recommended by WHO for all women in active labour; it plots cervical dilatation against time with an alert line (expected normal progress at 1 cm/hr) and an action line (4 hrs to the right of alert line).

Parameters recorded include: cervical dilatation and fetal head descent, uterine contractions (frequency, duration, strength), FHR every 30 min, liquor colour (clear/meconium), moulding, maternal pulse, BP, temperature, urine output, and drugs administered.

Importance: Early and objective detection of prolonged or obstructed labour; facilitates timely decision-making (augmentation or LSCS); prevents unnecessary interventions; improves communication between healthcare providers; has been shown to reduce rates of prolonged labour, emergency LSCS, stillbirth, and maternal morbidity especially in resource-limited settings.

6. Importance of Breastfeeding

Breast milk is the optimal nutrition for neonates, containing the perfect balance of proteins, fats, carbohydrates, vitamins, and minerals in bioavailable forms, along with colostrum (first milk, rich in secretory IgA, lactoferrin, and immune cells) that provides passive immunity and protects against neonatal infections.

WHO recommends: Exclusive breastfeeding for the first 6 months, followed by continued breastfeeding with complementary foods up to 2 years or beyond; breastfed infants have lower rates of SIDS, otitis media, diarrhoea, respiratory infections, obesity, and type 1 diabetes.

Benefits to mother: Promotes uterine involution (oxytocin release → reduces PPH), accelerates postpartum weight loss, provides natural contraception via LAM (Lactational Amenorrhoea Method) when exclusively breastfeeding + amenorrhoeic + <6 months (98% effective), and reduces lifetime risk of breast cancer, ovarian cancer, and osteoporosis.

all answers for Section II (Q1-Q4)

SECTION II — Q.1 (10 Marks)

Write in detail (any one of two)

Option 1: Fallopian Tube + Sterilization

a. Anatomy of Fallopian Tube

Paired hollow muscular tubes, 10-12 cm long, connecting uterine cornua to the ovary
Lie in the upper free border of the broad ligament (mesosalpinx)

Parts (medial → lateral):

Part	Length	Features
Interstitial (Intramural)	1 cm	Narrowest lumen (1 mm); passes through uterine wall; most common site of cornual ectopic
Isthmus	2-3 cm	Thick muscular wall, narrow lumen; site of tubal ligation and most ectopic pregnancies
Ampulla	5-6 cm	Widest, thin-walled; site of fertilization (most common) and ampullary ectopic
Infundibulum (Fimbria)	1-2 cm	Funnel-shaped opening; finger-like fimbriae (10-15); fimbria ovarica is longest, attached to ovary

Layers of wall (outer → inner):

Serosa - peritoneal covering (incomplete on inferior surface)
Muscularis - outer longitudinal + inner circular smooth muscle; peristaltic movements propel ovum
Mucosa - ciliated columnar epithelium + secretory (peg) cells; folds/plicae most elaborate in ampulla

Blood supply:

Medial 2/3: Uterine artery (tubal branch)
Lateral 1/3: Ovarian artery
Anastomose in the mesosalpinx

Nerve supply: T10-L2 sympathetic; pelvic splanchnic parasympathetic

Functions: Ovum pick-up (fimbriae), transport (cilia + peristalsis), site of fertilization, early embryo nutrition

b. Types of Permanent Female Sterilization

1. Laparoscopic (interval sterilization):

Falope ring (silastic band) - placed on isthmic loop
Filshie clip - titanium with silicone rubber
Bipolar cautery / electrocoagulation
Most common method in developed countries

2. Minilaparotomy (most common in India - interval and postpartum):

Small suprapubic incision (2-3 cm)
Pomeroy / Modified Pomeroy method
Parkland method
Irving method

3. Colpotomy: Through posterior vaginal fornix - rarely done

4. Hysteroscopic (transcervical):

Essure coil - now largely discontinued due to complications

c. Steps of Modified Pomeroy Method

Identify the isthmic portion of the fallopian tube (most commonly used site)
Grasp a knuckle (loop) of tube with Babcock forceps and elevate it
Ligate the base of the loop with plain catgut (No. 1) - absorbable suture
Excise the knuckle (1-2 cm segment of tube) above the ligature with scissors
Send excised segment for histopathological confirmation (medico-legal)
Check haemostasis; repeat on opposite side

Why plain catgut?

Absorbs rapidly (7-10 days) → two stumps spring apart → each end fibrose separately → permanent occlusion

Failure rate: 0.4-0.8 per 100 woman-years Most common cause of failure: Surgery during luteal phase (corpus luteum pregnancy already implanted)

d. Complications of Tubal Ligation

Immediate (intraoperative):

Anaesthetic complications (most common cause of death)
Haemorrhage - mesosalpinx bleeding
Bowel injury, bladder injury (laparoscopy)
Wound infection

Early postoperative:

Haematoma, wound dehiscence
Shoulder tip pain (laparoscopy - diaphragmatic irritation from CO2)

Late complications:

Ectopic pregnancy - if method fails, implantation in damaged tube
Post-tubal ligation syndrome - menstrual irregularities, dysmenorrhoea (debated; may be due to discontinuation of OCP)
Hydrosalpinx - proximal segment accumulates secretions
Regret - especially young women, change in marital status (reversal - only 40-50% success)
Psychological - regret, depression (especially if coerced)

Option 2: Precocious Puberty

Definition

Onset of puberty before age 8 in girls and age 9 in boys

Normal puberty sequence in girls: Breast → Pubic hair → Axillary hair → Growth spurt → Menarche (B-P-A-G-M)

Types and Causes

1. Central (True / GnRH-dependent) Precocious Puberty:

Premature activation of hypothalamo-pituitary-gonadal (HPG) axis
LH and FSH both elevated
Isosexual (same sex characteristics)
Girls: majority (80%) are idiopathic
Boys: majority have organic CNS cause - must investigate
CNS causes: hypothalamic hamartoma (most common organic cause), astrocytoma, craniopharyngioma, post-encephalitis, hydrocephalus, neurofibromatosis

2. Peripheral (Pseudo / GnRH-independent) Precocious Puberty:

Excess sex hormones from peripheral sources without HPG activation
LH/FSH suppressed (low)

Cause	Features
McCune-Albright syndrome	Café-au-lait spots + polyostotic fibrous dysplasia + autonomous ovarian cysts
Granulosa cell tumour (ovary)	Oestrogen-secreting; pelvic mass
Adrenal tumour / CAH	Androgens elevated; virilization
Leydig cell tumour (boys)	Testosterone elevated
Exogenous oestrogen	History of oestrogen-containing cream/OCP exposure
Hypothyroidism (Van Wyk-Grumbach)	Severe hypothyroidism → cross-reactivity with FSH receptor

Clinical Features (Girls)

Breast development (thelarche) before age 8 - first sign
Pubic and axillary hair (pubarche/adrenarche)
Vaginal discharge, growth spurt
Early menarche
Accelerated bone age → premature epiphyseal closure → short final adult height (most important consequence)
Psychological disturbance - social isolation, early sexual activity risk

Investigations

Investigation	Purpose
Bone age (X-ray left wrist)	Advanced bone age = significant puberty
Serum LH, FSH, Oestradiol	Elevated in central; suppressed in peripheral
GnRH stimulation test	LH:FSH ratio >1 after stimulation = central (pubertal response)
Pelvic USS	Ovarian volume, follicles, uterine size, any mass
MRI brain	Hypothalamic/pituitary lesion (mandatory in boys and when CNS cause suspected)
Serum DHEAS, 17-OHP	Adrenal cause (CAH - 17-OHP elevated)
Thyroid function	Van Wyk-Grumbach syndrome

Management

Central precocious puberty:

GnRH agonist (Leuprolide acetate depot 3.75 mg IM monthly or 11.25 mg every 3 months)
Mechanism: Continuous (non-pulsatile) GnRH → downregulates GnRH receptors → suppresses LH/FSH → arrests puberty
Arrests pubertal progression + allows bone age to normalize → better final height
Stop at appropriate age (10-11 years) → puberty resumes normally

Peripheral precocious puberty:

Treat underlying cause (tumour excision, hydrocortisone for CAH, levothyroxine for hypothyroidism)
McCune-Albright: aromatase inhibitors (letrozole, anastrozole)

All cases:

Psychological support and counselling for child and parents
Monitor growth velocity and bone age 6-monthly

SECTION II — Q.2 (12 Marks)

Case Scenario Based Questions (any two of three — 6 marks each)

CASE A: 63-year-old, something coming out P/V for 3 years

1. Probable Diagnosis

Third Degree Uterovaginal Prolapse (Procidentia)

Entire uterus lies outside the vaginal introitus with complete inversion of vaginal walls
Predisposing factors: Multiparity (stretching of supports), Menopause (oestrogen deficiency → atrophy of supports), chronic raised intra-abdominal pressure (chronic cough, constipation), poor perineal repair after delivery

2. Supports of the Uterus

Primary (main) supports - ligaments:

Ligament	Description
Transverse cervical (Cardinal / Mackenrodt's)	Most important; condensation of parametrium at base of broad ligament; supports cervix and upper vagina
Uterosacral ligaments	Pass from cervix posteriorly to sacrum; maintain anteversion/anteflexion
Pubocervical ligaments	Pass anteriorly from cervix to pubis
Round ligaments	Maintain anteversion only; weak support

Secondary supports - pelvic floor muscles:

Levator ani (most important structural support):
- Pubococcygeus
- Iliococcygeus
- Puborectalis (forms pubo-anorectal sling)
Urogenital diaphragm (perineal membrane)
Perineal body - central fibromuscular node; anchors perineal muscles

Tertiary supports:

Broad ligament, ovarian ligament (minimal support)
Vaginal walls themselves (upper 2/3 attached to pelvic fascia)

3. Management of 3rd Degree Uterovaginal Prolapse

Surgical (definitive - treatment of choice):

1. Vaginal Hysterectomy with Pelvic Floor Repair - most common and preferred in postmenopausal women with completed family:

Vaginal hysterectomy (removes uterus vaginally)
Anterior colporrhaphy - repair of cystocele (anterior wall prolapse)
Posterior colpoperineorrhaphy - repair of rectocele + perineal body repair
McCall culdoplasty - vault suspension to uterosacral ligaments (prevents vault prolapse post-hysterectomy)

2. Fothergill (Manchester) Operation - if uterus to be conserved (young/medically unfit for hysterectomy):

Amputation of elongated cervix
Plication of cardinal ligaments anterior to cervix
Anterior colporrhaphy + posterior repair
Disadvantage: risk of cervical stenosis, infertility, dystocia

3. Le Fort's Operation (Colpocleisis):

Partial obliteration of vaginal canal
Only for very elderly, unfit patients who are not sexually active
Simple and quick procedure

Conservative (for unfit/refusing surgery):

Ring pessary (Hodge or ring pessary) - inserted in vagina, changed every 3-6 months
Local oestrogen cream - improves vaginal atrophy, strengthens tissues
Pelvic floor exercises (Kegel's) - more useful for prevention and mild cases
Treat precipitating factors: chronic cough, constipation

CASE B: 46-year-old, menorrhagia for 3 years, pallor, uterus 6-8 weeks size on P/V

1. Differential Diagnosis

Diagnosis	Supporting features
Fibroid uterus (Leiomyoma) - most likely	Commonest cause of menorrhagia + enlarged uterus in perimenopausal woman; irregular, firm, non-tender uterus
Adenomyosis	Diffusely enlarged, soft, tender uterus; painful menorrhagia (dysmenorrhoea); uterus rarely >12 weeks size
Endometrial hyperplasia	Perimenopausal woman; irregular bleeding; must exclude
Endometrial carcinoma	Age 46, perimenopausal; irregular/postmenopausal bleeding; mandatory to exclude
Ovarian fibrothecoma	Can cause menorrhagia via oestrogen secretion; adnexal mass on USS

2. Management Protocols

Step 1 - Investigations (mandatory before treatment):

Pelvic USS (TVS preferred) - fibroid size, number, location (submucosal/intramural/subserosal), endometrial thickness
Endometrial sampling - Pipelle biopsy or D&C to exclude malignancy (mandatory in perimenopausal woman with menorrhagia)
CBC (Hb - anaemia), blood group
TFT (thyroid), coagulation profile
Hysteroscopy + biopsy (gold standard for intrauterine pathology)

Medical Management (if fertility desired or unfit/refusing surgery):

Drug	Dose	Mechanism
Tranexamic acid	500 mg TDS during menstruation	Antifibrinolytic; reduces loss by 50%
Mefenamic acid	500 mg TDS during menstruation	NSAID; reduces loss + dysmenorrhoea
Norethisterone	5 mg TDS (day 5-26)	Progestogen; suppresses endometrium
LNG-IUS (Mirena)	Inserted in OT	Releases 20 mcg LNG/day; reduces loss by 90%; best for adenomyosis too
GnRH agonist	Leuprolide 3.75 mg IM monthly x3-6 months	Reduces fibroid size 30-40%; corrects anaemia preoperatively; not long-term
Ulipristal acetate	5 mg OD x3 months	SPRM; fibroid size reduction

Surgical Management:

Procedure	Indication
Hysteroscopic myomectomy	Submucosal fibroid, fertility desired
Laparoscopic/abdominal myomectomy	Intramural/subserosal fibroid, fertility desired
Endometrial ablation	Uterus <12 weeks, no desire for fertility, no submucosal fibroid
Total hysterectomy (TAH/VH/TLH)	Definitive - completed family, failed medical therapy, large fibroid, exclude malignancy first

CASE C: 26-year-old, discharge PV + vulval itching 3 months, H/O Copper-T insertion 6 months ago

1. Differential Diagnosis

Diagnosis	Discharge character	Clue
Actinomyces infection	Yellowish-brown, foul	IUD use >6 months; Actinomyces israelii
Bacterial Vaginosis	Thin, grey, fishy smell	Most common in IUD users (altered flora)
Vulvovaginal Candidiasis	Thick, white, curdy	Intense vulval pruritus; no smell
Trichomoniasis	Frothy, yellow-green	Strawberry cervix; sexually transmitted
Chlamydial cervicitis	Mucopurulent, cervical	STI; contact bleeding
PID secondary to IUD	Purulent + pelvic pain	IUCD-related ascending infection

2. Management Protocols

Investigations first:

High vaginal swab - wet mount (clue cells, trichomonads, pseudohyphae), Gram stain, C&S
Endocervical swab - NAAT for Chlamydia and Gonorrhoea
Pap smear - look for Actinomyces on cytology
Pelvic USS - PID, tubo-ovarian abscess, IUD position
CBC, CRP (if PID suspected)

Treatment based on diagnosis:

Condition	Treatment
Actinomyces (on Pap smear)	Remove IUD + Penicillin G 10-20 MU IV x4 weeks OR Amoxicillin 500 mg TDS x6 weeks
BV	Metronidazole 400 mg oral BD x7 days OR Metronidazole 0.75% gel vaginally x5 nights
Candidiasis	Clotrimazole 100 mg vaginal pessary x6 nights OR Fluconazole 150 mg single oral dose
Trichomoniasis	Metronidazole 2g single oral dose; treat partner
Chlamydia	Azithromycin 1g single dose OR Doxycycline 100 mg BD x7 days
PID	Remove IUD after starting antibiotics; Ceftriaxone 500 mg IM + Doxycycline 100 mg BD x14d + Metronidazole 400 mg BD x14d

Counselling:

IUD-related risks explained
Safe sex practices
Consider alternative contraception (OCP, condoms) if recurrent infections

SECTION II — Q.3 (18 Marks)

Write a Short Note (any three of four — 6 marks each)

1. Pap Smear

Definition: Cytological screening test for detection of premalignant (CIN) and malignant lesions of the cervix by examining cells scraped from the transformation zone (squamocolumnar junction - most vulnerable area for carcinogenesis).

Procedure:

Visualize cervix with cusco's speculum (without lubricant)
Scrape ectocervix with Ayre's spatula (wooden/plastic, notched end at os)
Scrape endocervix with cytobrush
Smear on glass slide, fix immediately with 95% ethanol (prevent air-drying artefact)
Stain with Papanicolaou stain (5-step stain)
Liquid-Based Cytology (LBC/ThinPrep) - newer; cells dispersed in liquid fixative; better sensitivity, can do HPV co-testing on same sample

Bethesda System 2014 (Reporting):

Category	Meaning
NILM	Negative for Intraepithelial Lesion or Malignancy (normal)
ASC-US	Atypical squamous cells of undetermined significance
ASC-H	Cannot exclude HSIL
LSIL	Low-grade SIL = CIN 1 (HPV effect)
HSIL	High-grade SIL = CIN 2/3 (true premalignancy)
Squamous cell carcinoma	Malignant
AGC	Atypical glandular cells

Screening Intervals (WHO/ACS):

Age 21-29: Cytology alone every 3 years
Age 30-65: Cytology every 3 years OR co-testing (cytology + HPV) every 5 years
Stop at 65 if adequate negative prior screening
India (National guidelines): Screen all women 30-65 yrs; VIA + cytology

Management of Abnormal Pap:

ASC-US → HPV reflex testing or repeat cytology in 1 year
LSIL → Colposcopy
HSIL → Colposcopy + biopsy → CIN 2/3 → LEEP/CKC (large loop excision / cold knife conization)

Importance: Pap smear screening has reduced cervical cancer mortality by 70% in countries with organized programs.

2. Male Infertility

Definition: Failure to achieve pregnancy after 12 months of regular unprotected intercourse, attributable to a male factor; present in 40-50% of infertile couples (sole cause in 20%, contributing factor in 30-40%).

Causes:

Level	Causes
Pre-testicular (hormonal)	Hypogonadotropic hypogonadism - Kallmann syndrome, hyperprolactinaemia, obesity, anabolic steroids
Testicular (primary)	Varicocele (most common correctable cause - 35%), cryptorchidism, orchitis (mumps), Klinefelter's (47XXY), Y-chromosome microdeletion (AZF region), radiation, chemotherapy
Post-testicular (ductal/functional)	Obstructive azoospermia (CBAVD, epididymal obstruction), erectile dysfunction, retrograde ejaculation, antisperm antibodies

Investigations:

Semen Analysis (WHO 2021 reference values):

Parameter	Lower Reference Limit
Volume	≥1.4 mL
Concentration	≥16 million/mL
Total motility	≥42%
Progressive motility	≥30%
Normal morphology	≥4% (strict Kruger)
Vitality	≥54%

Repeat after 3 months (one spermatogenesis cycle) if abnormal
Hormone profile: FSH, LH, testosterone, prolactin
- High FSH = primary testicular failure (Sertoli cell dysfunction)
- Low FSH/LH = hypogonadotropic hypogonadism (treatable)
Karyotype - if azoospermia or severe oligospermia (Klinefelter's)
Y-chromosome microdeletion (AZFa, b, c)
Scrotal USS - varicocele, testicular volume, epididymal obstruction
Testicular biopsy - distinguish obstructive (normal spermatogenesis) vs non-obstructive azoospermia (maturation arrest, Sertoli cell only)
CFTR gene - CBAVD (congenital bilateral absence of vas deferens)

Management:

Condition	Treatment
Varicocele	Microsurgical varicocelectomy or embolization
Hypogonadotropic hypogonadism	hMG + hCG injections (gonadotropin therapy)
Obstructive azoospermia	PESA/MESA (epididymal sperm) or TESA + ICSI
Non-obstructive azoospermia	micro-TESE + ICSI (if sperm found)
Mild oligoasthenospermia	IUI (intrauterine insemination)
Severe/failed IUI	IVF-ICSI
Empirical	Antioxidants (CoQ10, Vitamin E, C, zinc, selenium), Clomiphene citrate

3. Polycystic Ovarian Syndrome (PCOS)

Definition: Most common endocrine disorder of reproductive-age women (prevalence 5-10%), characterized by a triad of hyperandrogenism, oligo/anovulation, and polycystic ovarian morphology, with associated metabolic dysfunction.

Pathophysiology:

Insulin resistance → hyperinsulinaemia → increased ovarian androgen production + decreased SHBG → hyperandrogenism
LH hypersecretion (LH:FSH ratio >2) → arrested follicular development → multiple small cysts
Chronic anovulation → unopposed oestrogen → endometrial hyperplasia risk

Diagnosis - Rotterdam Criteria 2003 (2 of 3):

Oligo/anovulation (cycles >35 days or <8 cycles/year)
Clinical hyperandrogenism (acne, hirsutism, androgenic alopecia) OR biochemical (elevated free testosterone/DHEAS)
Polycystic ovaries on USS: ≥12 follicles 2-9 mm in either ovary OR ovarian volume >10 mL

Other causes must be excluded: CAH, Cushing's, androgen-secreting tumour, hyperprolactinaemia, thyroid disease

Investigations:

Test	Finding in PCOS
LH:FSH ratio	>2 (suggestive, not diagnostic)
Free testosterone, DHEAS	Elevated
Fasting glucose + insulin	Insulin resistance (HOMA-IR >2.5)
75g OGTT	Screen for T2DM
Lipid profile	Dyslipidaemia (high LDL, low HDL)
USS pelvis	String of pearls appearance; ovarian volume >10 mL
TSH, prolactin	To exclude other causes

Management:

Lifestyle modification (cornerstone):

Weight loss of 5-10% → restores ovulation in 55-80%, reduces androgens, improves insulin sensitivity

For menstrual irregularity:

Combined OCP (ethinyl oestradiol + desogestrel/drospirenone) - regulates cycles, treats hirsutism/acne
Cyclical progestins (norethisterone day 14-26) - withdrawal bleed every 3 months

For infertility (ovulation induction - stepwise):

Letrozole 2.5-7.5 mg/day (aromatase inhibitor) - now preferred 1st line
Clomiphene citrate 50-150 mg/day (days 2-6) - anti-oestrogen
Metformin 500-1000 mg BD - insulin sensitizer, restores ovulation, reduces miscarriage
Gonadotropins (hMG/rFSH) - with USS monitoring; risk of OHSS
LOD (Laparoscopic Ovarian Drilling) - 4-point drilling with diathermy/laser; reduces LH, restores FSH:LH ratio; equivalent to gonadotropins

For hirsutism:

OCP + anti-androgens: Spironolactone 50-100 mg/day, Cyproterone acetate

Long-term risks (counsel patients):

Type 2 DM (4-8x increased risk)
Cardiovascular disease
Endometrial carcinoma (chronic anovulation + unopposed oestrogen)
Sleep apnoea, depression

4. Vaginal Infections

Classification and Comparison:

Feature	Bacterial Vaginosis	Vulvovaginal Candidiasis	Trichomoniasis
Organism	Gardnerella vaginalis + anaerobes (Prevotella, Mobiluncus)	Candida albicans (80-90%)	Trichomonas vaginalis (flagellated protozoan)
Discharge	Thin, homogeneous, grey-white, adherent	Thick, white, curdy/cottage cheese	Frothy, profuse, yellow-green
Odour	Fishy (amine odour)	Absent	Offensive
Itching	Minimal	Intense vulval pruritus	Moderate, vulvovaginal
Dysuria	Absent	Occasional	Present
Vaginal pH	>4.5	<4.5	>4.5
Wet mount	Clue cells (epithelial cells studded with bacteria)	Pseudohyphae + budding spores	Motile flagellated protozoa
Whiff test (KOH)	Positive (fishy amine smell)	Negative	Negative
Cervix	Normal	Erythematous	Strawberry cervix (colpitis macularis)
Treatment	Metronidazole 400 mg BD x7 days OR vaginal gel x5 nights	Fluconazole 150 mg single dose OR Clotrimazole pessary	Metronidazole 2g single dose; treat partner

Amsel's criteria for BV diagnosis (3 of 4):

Thin homogeneous grey discharge
pH >4.5
Positive whiff test
Clue cells on wet mount

Cervicitis (STI):

Chlamydia trachomatis: mucopurulent discharge, contact bleeding, cervical friability; NAAT for diagnosis; Azithromycin 1g single dose OR Doxycycline 100 mg BD x7 days; notify + treat partner
Neisseria gonorrhoeae: profuse purulent discharge; Gram stain - intracellular Gram -ve diplococci; Ceftriaxone 500 mg IM single dose + Azithromycin 1g; increasing resistance to quinolones

Actinomyces (IUD-associated):

Actinomyces israelii - commensal in oral/GI tract; pathogenic with long-term IUD use
Yellow sulphur granules in discharge
Pap smear shows Actinomyces filaments
Management: Remove IUD + Penicillin G IV x4 weeks

SECTION II — Q.4 (10 Marks)

Write in 2-3 Sentences (any 5 of 6 — 2 marks each)

1. Types of IUDs and Their Eligibility Criteria

Copper-bearing IUDs (Cu-T 380A, Cu-T 200B, Multiload 375, Nova-T): Act by spermicidal effect of copper ions, impaired sperm motility, and hostile endometrial environment; effective for 5-10 years; also used as emergency contraception within 5 days of unprotected intercourse.

Hormonal IUDs (LNG-IUS/Mirena, Kyleena): Release levonorgestrel 20 mcg/day; act by endometrial atrophy, cervical mucus thickening, and partial anovulation; effective for 5-7 years; reduce menstrual blood loss by 90% (ideal for menorrhagia/adenomyosis).

Eligibility (WHO MEC): Suitable for parous/nulliparous women, postpartum (after 6 weeks), postabortal; Contraindicated (Category 4) in: pregnancy, active/recent PID or STI, unexplained vaginal bleeding, uterine anomaly/distorted cavity, cervical/endometrial carcinoma, copper allergy (for Cu-IUD), current DVT/PE (for LNG-IUS with caution).

2. Ovulation Inducing Agents

Clomiphene citrate (anti-oestrogen, SERM): 50-150 mg/day on days 2-6 of cycle; blocks oestrogen receptors in hypothalamus → increased GnRH → FSH/LH surge → follicular growth; first-line for anovulatory infertility; multiple pregnancy rate 8-10%; antioestrogen effect on endometrium and cervical mucus is a drawback.

Letrozole (aromatase inhibitor, 3rd generation): 2.5-7.5 mg/day days 2-6; inhibits oestrogen synthesis → removes negative feedback → FSH rise → mono-follicular development; now preferred over clomiphene in PCOS (better live birth rates, lower multiple pregnancy risk, no antioestrogen peripheral effects).

Other agents: Gonadotropins (hMG, rFSH) - for clomiphene-resistant cases; require USS monitoring; risk of OHSS; Metformin - insulin sensitizer in PCOS, restores ovulation; GnRH pulsatile therapy - for hypothalamic amenorrhoea; Bromocriptine/cabergoline - for hyperprolactinaemic anovulation.

3. Types of Dysmenorrhoea

Primary dysmenorrhoea occurs without identifiable pelvic pathology, most common in young nulliparous women (within 1-2 years of menarche); caused by excess prostaglandins (PGF2α, PGE2) leading to uterine hypercontractility and ischaemia; pain is spasmodic, lower abdominal, begins with onset of flow, lasts 24-48 hours; managed with NSAIDs (mefenamic acid, ibuprofen - start 1-2 days before flow) or combined OCP (suppress ovulation, reduce prostaglandins).

Secondary dysmenorrhoea has an identifiable organic pelvic cause; pain typically begins 1-2 weeks before menstruation (premenstrual), worsens with flow, and may persist throughout; common causes: endometriosis (most common), adenomyosis, submucous fibroids, PID, cervical stenosis, IUCD; dyspareunia and infertility often coexist; management targets the underlying cause (laparoscopy for endometriosis, hysterectomy for adenomyosis).

4. Hormone Replacement Therapy (HRT)

HRT is the exogenous administration of oestrogen (with or without progestogen) to relieve menopausal symptoms (vasomotor - hot flushes, night sweats; urogenital atrophy - vaginal dryness, dyspareunia; psychological - mood changes, sleep disturbance) and prevent osteoporosis and cardiovascular disease in early menopause.

In women with intact uterus: combined oestrogen + progestogen is mandatory (sequential or continuous combined) to prevent oestrogen-induced endometrial hyperplasia/carcinoma; in post-hysterectomy women: oestrogen alone is sufficient.

Absolute contraindications: Oestrogen-receptor positive breast/endometrial cancer, unexplained vaginal bleeding, active DVT/PE/thrombophilia, active liver disease, uncontrolled hypertension; minimum effective dose for shortest duration is the current principle (WHI study showed increased risk of breast cancer, DVT with long-term combined HRT).

5. Indications of Dilation and Curettage (D&C)

Diagnostic indications: Abnormal uterine bleeding (perimenopausal, postmenopausal, DUB unresponsive to medical therapy) - to obtain endometrial tissue and exclude hyperplasia/malignancy; infertility workup (irregular endometrium, synechiae); before cervical amputation or cone biopsy.

Therapeutic indications: Evacuation of incomplete, missed, or septic abortion (retained products of conception); removal of endometrial polyps; postmolar/post-abortal haemorrhage; treatment of intrauterine adhesions (Asherman's syndrome - hysteroscopic adhesiolysis preferred); cervical stenosis dilatation.

Largely replaced by: Pipelle biopsy (outpatient endometrial sampling - diagnostic), hysteroscopy-guided procedures (therapeutic - gold standard for intrauterine pathology under direct vision), and suction evacuation/MVA for abortion management.

6. Indications of Laparoscopy in Gynaecology

Diagnostic laparoscopy: Unexplained chronic pelvic pain; infertility workup - direct visualisation of pelvis + chromopertubation (dye test for tubal patency); confirmation and staging of endometriosis; suspected ectopic pregnancy (when USS inconclusive); suspected PID, ovarian torsion; staging of gynaecological malignancies.

Therapeutic (operative) laparoscopy: Ovarian cystectomy, oophorectomy, salpingectomy; ectopic pregnancy management (salpingotomy or salpingectomy - preferred over laparotomy); adhesiolysis; endometriosis ablation/excision; LOD (laparoscopic ovarian drilling for PCOS); myomectomy; sterilization (Falope ring, Filshie clip, bipolar cautery); TLH (total laparoscopic hysterectomy) / LAVH.

Advantages over laparotomy: Shorter hospital stay, less postoperative pain, smaller incisions, faster recovery, reduced adhesion formation, magnified view for better precision.

This is a shared conversation. Sign in to Orris to start your own chat.